Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Endocrinology
Disease Category: High Cholesterol (Hyperlipidemia)
Trial Information
Cholesterol Study
A research study to evaluate the effectiveness and safety of the
study medication in combination with “statins” compared with
“statins” alone for 12 weeks in subjects with hypercholesterolemia
(high cholesterol). An optional 48-week extension period will
follow the 12-week treatment period.
To be eligible, you must:
- Be at least 18 years old
- Have dyslipidemia (high cholesterol)
- Be taking a stable dose of “statin” medication for at least 3
months
Study participation includes all study-related labs, exams, and
study medication. Compensation may be provided for qualified
participants.
For more information,
Vikki A. Wiener, D.O., Medical Director
Horizon Clinical Research Associates, PLLC
2730 S. Val Vista Dr., Suite 169
Gilbert, AZ 85295
Phone: 480-981-8339
EMail: admin@horizonresearchaz.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
